Skip to main content

Zeldis Jerome B

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Zeldis Jerome B as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

PTCT PTC Therapeutics, Inc.

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 4, 2024 (view filing)Dec 22 daysZeldis Jerome BDirectorSSale−24.0K$51.50−$1.24M−62.3%14.5K after5 lots10b5-1
May 24, 2024 (view filing)May 222 daysZeldis Jerome BDirectorSSale−20.0K$38.24−$764.8K−58.0%14.5K after10b5-1

NXGL Nexgel, Inc.

Director5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 22, 2024 (view filing)Nov 202 daysZeldis Jerome BDirectorPPurchase+3.64K$2.75+$10.0K+3.5%106.7K after
Aug 27, 2024 (view filing)Aug 234 daysZeldis Jerome BDirectorPPurchase+10.0K$2.50+$25.0K+10.7%103.0K after
May 30, 2023 (view filing)May 264 daysZeldis Jerome BDirectorPPurchase+5.00K$2.34+$11.7K+5.7%93.0K after
Mar 28, 2022 (view filing)Mar 253 daysZeldis Jerome BDirectorPPurchase+5.30K$1.89+$10.0K+6.4%88.0K after
Jan 3, 2022 (view filing)4:46 PM ETDec 27, 20217 daysLateZeldis Jerome BDirectorPPurchase+9.09K$5.49+$49.9K+12.3%82.7K after